- Moderna (MRNA) raises lower end of its 2021 global COVID-19 vaccine manufacturing plan to 600 million doses
Notícias do Mercado
4 janeiro 2021
Moderna (MRNA) raises lower end of its 2021 global COVID-19 vaccine manufacturing plan to 600 million doses
Moderna increased its base-case global production estimate for its COVID-19 vaccine from 500 million to 600 million doses for 2021. It said that it is continuing to invest and add staff to build up to potentially 1 billion doses for 2021.
The company also said it expects about 100 million doses to be available in the U.S. by the end of Q1 2021, with 200 million doses total available by the end of Q2.
O foco de mercado
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimerAbrir Conta Demo e Página Pessoal